Medical Devices Market
| PRODUCT TITLE | PUBLISHED | |
|---|---|---|
 |
Electrical Ablators The global electrical ablator market, mainly driven by the increasing aging population with higher risk of chronic disease and increasing procedures through minimal invasive surgery, was valued at $785 million in 2013 and is expected to reach $1006 million by 2018. The main companies operating in this market and extensively covered in this report are ConMed Corporation (U.S), Medtronic (U.S), Boston Scientific Corporation (U.S), AngioDynamics (U.S), and Covidien plc (Ireland). |
Upcoming |
|
|
Global Passive Transdermal Drug Delivery Market The Global Passive Transdermal Drug Delivery Market is mainly driven by patent cliffs and increased incidence of chronic diseases, increasing competition and improving patient compliance, and reformulation and repositioning of drugs, huge investment made by big pharmaceutical companies.The Market was Valued at $12.27 billion in 2013 and expected to be $20.59 billion by 2018, growing at a CAGR of 10.9 %. The Transdermal Drug Delivery Market analyzes the market by segments such as Active Transdermal Drug Delivery, and Passive Transdermal Drug Delivery. The prominent players in this Market are Novartis, Johnson & Johnson, 3M Company, Noven. |
Upcoming |
|
|
Active Active and Microfluidics, Smart Pill Technology (SPT) and Passive adds up to... |
Upcoming |
|
|
Optical Coherence Tomography Optical Coherence Tomography and Photo-Acoustic, Hyperspectral... |
Upcoming |
|
|
Photo-Acoustic Photo-Acoustic and Optical Coherence Tomography, |
Upcoming |
|
|
Near-Infrared Spectroscopy Near-Infrared Spectroscopy and Optical Coherence Tomography, |
Upcoming |
|
|
Prefilled Prefilled and Fillable adds up to total Injectables Drug... |
Upcoming |
|
|
Fillable Fillable and Prefilled adds up to total Injectables Drug... |
Upcoming |
|
|
Disposable Disposable and Reusable adds up to total Injectables Drug... |
Upcoming |
|
|
Reusable Reusable and Disposable adds up to total Injectables Drug... |
Upcoming |
|
|
Standardized Auto Injectors Standardized Auto Injectors and Customized Auto Injectors adds up to total |
Upcoming |
|
|
Customized Auto Injectors Customized Auto Injectors and Standardized Auto Injectors adds up to total |
Upcoming |
|
|
Center Use Hemodialysis Center Use Hemodialysis and Home Hemodialysis, |
Upcoming |
|
|
Home Hemodialysis Home Hemodialysis and Center Use Hemodialysis, |
Upcoming |
|
|
Continuous Cycling Peritoneal Dialysis (CCPD) Continuous Cycling Peritoneal Dialysis (CCPD) and Center Use Hemodialysis, |
Upcoming |
|
|
Continuous Ambulatory Peritoneal Dialysis (CAPD) Continuous Ambulatory Peritoneal Dialysis (CAPD) and Center Use Hemodialysis, |
Upcoming |
|
|
Intermittent PD (IPD) Intermittent PD (IPD) and Center Use Hemodialysis, Home... |
Upcoming |
|
|
PD Plus Therapy PD Plus Therapy and Center Use Hemodialysis, Home... |
Upcoming |
|
|
Peritoneal Dialysis The “Global Peritoneal dialysis Market”, mainly driven by increase in the number of ESRD patient population, was pegged at $ 9.1 billion in 2012 and expected to be $ 16.4 billion by 2020, growing at a CAGR of 7.6%. The market has 2 main segments such as Peritoneal dialysis product and Peritoneal services. The main companies operating in Peritoneal dialysis market, extensively covered in this report are Baxter International, Inc. (U.S.) and Fresenius Medical CareAG & Co. KGaA (Germany), etc. |
Upcoming |
|
|
Blood glucose monitors Blood glucose monitors and Blood pressure monitors, |
Upcoming |
infertility Treatment
